Rainer Baule

Rainer Baule is currently the Chairman at NPBI International BV, Chairman-Supervisory Board at Fresenius Hemocare Netherlands B.V., Director at Calea Ltd., Director at Fresenius Kabi España SA, Director-Administrative Board at Fresenius Kabi Italia Srl, Director at Fresenius Kabi Asia Pacific Ltd., Director at Dabur Pharma (Thailand) Co., Ltd., Director at Fresenius Kabi Pharmaceuticals Holding, Inc. (United States), Managing Director at Baule GmbH, Co-Managing Director at ACQUIFER Imaging GmbH, Trustee at Else Kröner-Fresenius-Stiftung, Principal at MC Medizintechnik GmbH, Member-Supervisory Board at Amann Girrbach AG, Member-Supervisory Board at Labesfal-Laboratórios Almiro SA, and Member-Supervisory Board at Ditabis Digital Biomedical Imaging Systems AG.
Formerly, Mr. Baule was the Chief Executive Officer at Fresenius Kabi AG from 2001 to 2010.
He also served as the Chief Executive Officer at EG&G Berthold GmbH & Co. KG in 1997.
Additionally, he was the Chairman-Supervisory Board at Vorwerk SE & Co. KG, Deputy Chairman-Supervisory Board at STRATEC SE, Chairman-Administrative Board at Fresenius Kabi France SA, Chairman-Supervisory Board at Fresenius Kabi Austria GmbH, Chairman-Supervisory Board at Metechon AG, Director at APP Pharmaceuticals, Inc., Director at FHC (Holdings) Ltd. from 2001 to 2012, Director at Fresenius Kabi Oncology Plc, Member-Management Board at Fresenius SE & Co. KGaA from 1997 to 2001, Executive Vice President-Division at Carl Zeiss AG, and Management Partner at Komeg-Kontroll-Technik GmbH from 1975 to 1979.
He was also a Member-Management Board at Fresenius Management SE in 2012.
Mr. Baule obtained his undergraduate degree from Technische Universität Darmstadt in 1974.